Skip to main content
. 2023 Jan 10;13:1063002. doi: 10.3389/fimmu.2022.1063002

Figure 4.

Figure 4

Separation of antibodies by size exclusion chromatography. The elution profiles showed a major peak of (A) anti-EGFR/HER2 BsAb, (B) pertuzumab, (C) anti-CD20/CD20 BsAb, and (D) rituximab with a retention time that is consistent with their expected molecular weight of around 144-145 kDa, respectively. All SEC experiments were done in triplicate. Chromatograms shown here are representative of the results.